ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620277 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620277; 2) Community: the network communities that were significantly associated with the response to NSC 620277; 3) Molecule: the relationships between components within communities and NSC 620277; 4) MDR: the compounds that were significantly associated with the NSC 620277.

NSC Compound Enrichment Correlation
NSC 71669 Null 0.00140570135773563 0.50816167
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.00140570135773563 0.30279964
NSC 726267 Null 0.00140570135773563 -0.2278753
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.00140570135773563 0.41632318
NSC 756404 GW843682X 0.00140570135773563 0.34727193
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.00172065213317242 -0.2360867
NSC 668259 Null 0.00172065213317242 0.35752852
NSC 677640 Null 0.00172065213317242 -0.25693716
NSC 733755 Null 0.00172065213317242 0.16631521
NSC 734982 Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate 0.00172065213317242 -0.28292484
Total:139  Current:12    [First] [Prev] [Next] [Last]